Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting: Rationale and Design of the DANFLU-1 Trial

LANDRAY M.

Type

Journal article

Journal

Pilot and Feasibility Studies

Publisher

BMC

Publication Date

07/04/2022

Permalink